Team
Management
Govert J. Schouten, Ph.D. (1967)
Chief Executive Officer
Dr. Govert Schouten is Chief Executive Officer. He joined Mucosis in May of 2008. Prior to that, Dr. Schouten served as Vice President of Business Development at Crucell. He worked at Crucell for almost 12 years, and was responsible for the global vaccine business development activities. He holds a Ph.D. in virology from Leiden University, The Netherlands.
Cornelis J. Leenhouts, Ph.D. (1959)
Chief Scientific Officer
Dr. Kees Leenhouts is co-founder and Chief Scientific Officer. Previously, Dr. Leenhouts was program manager at Biomade Technology Foundation, and responsible for intranasal vaccine technology development. He spent two years as research fellow at the International Centre for Genetic Engineering and Biotechnology in Trieste, Italy. Dr. Leenhouts is inventor of the Mimopath™ technology. He holds a Ph.D. in biology from the University of Groningen.
Supervisory Board
Willem Hazenberg Ph.D. (1967)
Chairman of the supervisory board
Dr. Hazenberg served as chairman of the supervisory board since August 2007. He is partner at BioGeneration Ventures B.V., an early stage Life Sciences venture capital fund with a focus on The Netherlands. He has entrepreneurial experience in creating and working with a large number of start-up companies in the sector.
Otto H. Postma M.Sc. (1952)
Member of the supervisory board
Mr. Postma served as member of the supervisory board since August 2007. He is senior investment manager at MedScience Capital B.V. He co-founded (the predecessor of) Pharming Group N.V., founded and managed Pharming Healthcare, Inc., and was instrumental in the establishment or early development of several Dutch life sciences start-ups.